Buys
Open market- Shares
- Avg price
- Total value
Stuart Cobb - Chief Scientific Officer at Neurogene Inc.
Issuer-level insider activity
- Role
- Chief Scientific Officer
- Issuer ticker
- NGNE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Stuart Cobb in Neurogene Inc.
Sells
Open market- Shares
- -6,797
- Avg price
- $20.81
- Total value
- -$141,446
Net
Past year- Shares
- -6,797
- Share %
- -100%
- Total value
- -$141,446
Reported holdings for Stuart Cobb in Neurogene Inc.
Form 4 holding
Chief Scientific Officer
Neurogene Inc.
- Security class
- Common Stock
- Shares / value
- 30,497
- Estimated value
- $673,373
- Report date
- 13 Mar 2026
- Price
- $22.08
- Ownership
- Direct
Form 4 holding
Chief Scientific Officer
Neurogene Inc.
- Security class
- Employee Stock Option (Right to buy)
- Shares / value
- 42,900
- Estimated value
- Report date
- 26 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Stuart Cobb in Neurogene Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.